Genetic Variation by RNA Splicing May Lead to Tumor Aggressiveness and Drug Resistance in African American Men with Prostate Cancer
June 30, 2017
Norman Lee, PhD, professor of pharmacology and physiology, published research in Nature Communications finding that a form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer.
June 22, 2017
When chronic, unresponsive eruptions don't respond to standard treatments, think cutaneous T-cell lymphoma, says L. Frank Glass, MD in an interview with Adam Friedman, MD.
June 14, 2017
WASHINGTON (June 14, 2017) - Today some patients suffering with mantle cell lymphoma, a type of blood cancer, can be treated with a pill called ibrutinib, forgoing conventional chemotherapy. However, many are developing a resistance to this treatment.
April 7, 2017
Adam Friedman, M.D., Associate Professor of Dermatology at the GW School of Medicine and Health Sciences, wrote an article for the Huffington Post on avoiding ultraviolet radiation.
November 16, 2016
George Washington University (GW) researchers received a $2.2 million grant from the National Cancer Institute to uncover why certain cancer types increase whereas others are unchanged or even decrease in those with HIV infection.